StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
6
Publishing Date
2021 - 09 - 13
6
Sector
Health technology
6
Tags
5g
4
Acquisition
8
Alliances
5
Application
3
Authorized
4
Biopharma
9
Bioscience
5
Biotech
3
Biotech-bay
4
Brands
4
Cancer
9
Ceo
4
Clinical-trials-phase-ii
4
Collaboration
9
Commercialization
4
Communication
4
Communications
3
Conference
41
Contract
5
Covid
8
Covid-19
4
Diagnostic
4
Diagnostics
3
Disease
4
Drug
5
Electronics
3
Energy
4
Europe
12
Events
15
Expansion
4
Financial results
6
Growth
18
Iot
7
Life science
5
Media
8
Merge
6
Mergers-and-acquisitions
4
Mobile
5
N/a
376
Offering
15
Ongoing
5
Partnership
7
People
4
Pharm-country
6
Phase 1
6
Phase 2
13
Phase 2b
6
Phase 3
5
Positive
12
Potential
7
Presentation
12
Research
25
Response
8
Results
21
System
5
Technology
14
Test
8
Therapy
5
Treatment
7
Trial
27
Entities
Atyr pharma, inc.
2
Bellus health inc.
1
Hepion pharmaceuticals, inc.
1
Igm biosciences, inc.
1
Monopar therapeutics inc.
1
Symbols
BLU
1
HEPA
1
IGMS
1
LIFE
2
MNPR
1
Exchanges
Nasdaq
6
Crawled Date
2023 - 01 - 09
4
2022 - 12 - 15
4
2022 - 12 - 13
4
2022 - 10 - 26
5
2022 - 06 - 29
4
2022 - 06 - 06
4
2022 - 06 - 02
5
2022 - 04 - 26
4
2022 - 04 - 04
4
2022 - 01 - 26
3
2022 - 01 - 24
4
2022 - 01 - 20
5
2022 - 01 - 05
4
2021 - 12 - 16
4
2021 - 12 - 15
4
2021 - 12 - 13
5
2021 - 12 - 06
5
2021 - 12 - 01
4
2021 - 11 - 30
4
2021 - 11 - 15
4
2021 - 11 - 12
3
2021 - 11 - 11
3
2021 - 10 - 27
3
2021 - 10 - 19
3
2021 - 10 - 13
3
2021 - 10 - 07
3
2021 - 10 - 04
4
2021 - 10 - 01
5
2021 - 09 - 30
3
2021 - 09 - 29
4
2021 - 09 - 13
6
2021 - 09 - 09
6
2021 - 09 - 08
5
2021 - 08 - 31
4
2021 - 08 - 25
3
2021 - 08 - 23
3
2021 - 08 - 05
3
2021 - 07 - 26
5
2021 - 07 - 22
3
2021 - 07 - 09
4
2021 - 06 - 30
4
2021 - 06 - 24
4
2021 - 06 - 23
5
2021 - 06 - 16
3
2021 - 06 - 10
3
2021 - 06 - 09
3
2021 - 06 - 08
3
2021 - 06 - 02
3
2021 - 05 - 12
3
2021 - 04 - 20
6
2021 - 04 - 15
3
2021 - 03 - 24
3
2021 - 03 - 15
4
2021 - 03 - 09
3
2021 - 02 - 24
3
2021 - 01 - 27
3
2020 - 12 - 15
5
2020 - 12 - 10
3
2020 - 12 - 08
3
2020 - 12 - 01
4
Crawled Time
08:00
1
12:00
3
13:00
1
19:00
1
Source
www.biospace.com
3
www.globenewswire.com
2
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Phase 2b
crawled date :
2021 - 09 - 13
save search
Additional Data from Hepion Pharmaceuticals’ Phase 2a ‘AMBITION’ Trial Further Strengthens CRV431 Clinical Profile and Paves Way for Initiation of Phase 2b ‘ASCEND-NASH’ Clinical Program
Published:
2021-09-13
(Crawled : 19:00)
- biospace.com/
HEPA
|
$1.47
4.26%
4.08%
71K
|
Health Technology
|
-15.06%
|
O:
4.82%
H:
0.57%
C:
-3.45%
phase 2
phase 2b
nash
trial
crv431
Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe
Published:
2021-09-13
(Crawled : 13:00)
- biospace.com/
MNPR
|
$0.631
-0.16%
-0.32%
86K
|
Health Technology
|
-88.67%
|
O:
2.34%
H:
2.28%
C:
-9.67%
phase 2
europe
phase 2b
trial
BELLUS Health Announces Positive Interim Analysis from the Phase 2b SOOTHE Trial of BLU-5937 in Refractory Chronic Cough
Published:
2021-09-13
(Crawled : 12:00)
- biospace.com/
BLU
|
$14.74
0.03%
0
|
Health Technology
|
276.02%
|
O:
20.66%
H:
8.88%
C:
1.06%
phase 2
positive
chronic cough
phase 2b
trial
blu-5937
aTyr Pharma and its Hong Kong Subsidiary, Pangu BioPharma, Announce Positive Data from a Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response of ATYR1923 in Pulmonary Sarcoidosis
Published:
2021-09-13
(Crawled : 12:00)
- globenewswire.com
LIFE
|
$1.62
-1.22%
-1.23%
220K
|
Health Technology
|
-70.07%
|
O:
14.96%
H:
47.46%
C:
45.24%
biopharma
phase 1
positive
trial
phase 1b
phase 2b
aTyr Pharma Announces Positive Data from Phase 1b/2a Clinical Trial Demonstrating Consistent Dose Response for ATYR1923 in Pulmonary Sarcoidosis
Published:
2021-09-13
(Crawled : 12:00)
- globenewswire.com
LIFE
|
$1.62
-1.22%
-1.23%
220K
|
Health Technology
|
-70.07%
|
O:
14.96%
H:
47.46%
C:
45.24%
phase 1
positive
trial
phase 1b
phase 2b
response
Abstract for MIV-818 phase 1b monotherapy for ESMO Congress published
Published:
2021-09-13
(Crawled : 08:00)
- prnewswire.com
IGMS
|
$7.73
14.52%
12.68%
410K
|
Health Technology
|
-90.69%
|
O:
0.0%
H:
2.58%
C:
-1.23%
phase 1
therapy
phase 1b
phase 2b
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.